Skip to Main Content

Paper Details

Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.
Oncotarget
38
2015
B-cell lymphomas, COP-9 signalosome, COP9, COP9-signalosome, CSN, CSN5, DLBCL, DLBCL cell, DLBCL cells, HSP90, diffuse large B-cell lymphoma, diffuse large B-cell lymphoma (DLBCL) cells, diffuse large B-cell lymphomas, doxycycline, mouse, non-Hodgkin lymphoma, non-Hodgkin lymphoma cells, non-Hodgkin lymphomas
Author NameAffiliation
Veronica Clavijo JordanWilmot Cancer Institute, University of Rochester Medical Center
Veronica Clavijo JordanUniversity of Colorado Denver
Veronica Clavijo JordanWilmot Cancer Institute, University of Rochester Medical Center
Veronica Clavijo JordanUniversity of Colorado Denver
Hartmut LandUniversity of Rochester Medical Center
Hartmut LandWilmot Cancer Institute, University of Rochester Medical Center
  • 1 - 6

Datasets

Release 1.2